银屑病关节炎市场，[患病状况（轻度银屑病关节炎，严重的银屑病关节炎，中等银屑病关节炎）;通过机理型（PDE 4抑制剂，白细胞介素阻滞剂，TNF抑制剂，其他）;通过最终使用（药店，零售药房，医院药房，在线药房）];和地理 - 趋势，分析和预测直到2025年

Report Summary

The Global Psoriatic Arthritis Market Size is expected to gain traction due to the rising need for treating psoriatic arthritis. Also, changing lifestyle results in the growth of population suffering from psoriatic arthritis.

Psoriatic arthritis is majorly found in the individuals suffering frompsoriasis占患有银屑病关节炎的人口的约30％。此外，它可以被称为刺激性，不可预测的令人困惑的皮肤病。牛皮癣主要发生在膝盖，肘部，头皮，躯干，棕榈树和脚底。它是一种自身免疫疾病，导致炎症触发关节疼痛，僵硬和肿胀。银屑病关节炎可以特征在于症状，如下背部疼痛，肿胀的关节，脚疼痛，指甲蚀，疲劳和减少的运动范围。银屑病关节炎也会导致称为脊椎的脊柱炎症。银屑病关节炎通常用各种抗炎药物组合治疗（NSAID）治疗。

Psoriasis influences psoriatic arthritis, which leads to swelling in the joints. According to National Psoriasis Foundation about 10% to 30% of people suffering from psoriasis suffer from psoriatic. The cause of psoriasis is unknown, but some factors such as genetics, change in lifestyle, psoriasis and medication. On the other hand, small percentage of people suffering from psoriatic arthritis may develop mutilan arthritis that leads to severe pain and disabling. In arthritis mutilan the small bones of the body are disabled leading to permanent deformity and disability in an individual.

持续技术进步对银屑病关节炎进行新建治疗，迎合对银屑病关节炎的未满足需求，以及不断变化的人口生活方式将支持全球牛皮癣药物市场的增长。

The global psoriatic arthritis market is primarily driven by growing number of patients from all age group suffering from psoriasis. Additionally, increased consumption of alcohol and changing lifestyle of individuals, increasing incidences of smoking, and rising demand for improved healthcare would also grow the psoriasis drugs market.

While, increasing number of clinical trials for developing new combination drugs along with the strong, and growing R&D funding and investments on healthcare by the governments of developing and developed economies, unhealthy living, excess consumption of fats and unmet needs for effective treatments influence the market growth during the forecast period.

However, no proper cure for psoriasis, and side effects caused due to the medical treatment to hinder the growth of psoriatic arthritis market in the near future.

Global Psoriatic Arthritis Market Taxonomy

全球市场分割的基础上说ease condition, mechanism type, end use and geography

On the basis of disease condition, market is segmented into:

• 轻度银屑病关节炎
• 严重的银屑病关节炎
• Moderate Psoriatic Arthritis

On the basis of mechanism type, market is segmented into:

• PDE 4 Inhibitors
• 白细胞介素受阻者
• TNF Inhibitors
• 其他

在最终使用类型的基础上，市场被分段为：

• Drug Store
• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

Geographically, the global market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

高标准的TNF抑制剂，导致其在美国越来越偏好的偏好，越来越多的患有牛皮癣的患者，以引领北美的银屑病关节炎市场。

North America is expected to dominate this market over the forecast period. North America holds major share owning to the continuous technological developments by the increasing R&D investments by the major players and government, and increasing number of key players invest in this region. Also, increasing number of patients suffering from psoriasis in the U.S. would spur the market of North America. While, increasing awareness for the use of combination NSAIDs would also spur the psoriatic arthritis market in North America.

However, Asia Pacific psoriatic arthritis market is observed to grow at a faster rate owing to the developing healthcare infrastructure, and rising need for treating the growing number of patients suffering from psoriatic arthritis.

全球性资料关节炎市场的主要球员是：

• Amgen Inc.
• AbbVie Inc.
• Johnson & Johnson Inc.
• 诺华AG
• Eli Lily and Company
• Astazenca PLC
• Celgene Corporation
• Sun Pharma
• Boehringer Ingelheim
• Jansenn Global Services
• Hoffmann-la Roche AG
• Bristol-Myers Squibb Company.